Sponsor

Agouron Pharmaceuticals

Clinical research sponsor

Published trials17
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

17 shown
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing NelfinavirNCT00006326 · lead sponsor · 2000-08-01
TERMINATED
A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV TreatmentsNCT00006211 · lead sponsor · 2000-02-01
COMPLETED
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination TherapyNCT00004985 · lead sponsor · 2000-01-01
COMPLETED
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsNCT00005000 · lead sponsor · 1999-12-01
UNKNOWN
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected PatientsNCT00004998 · lead sponsor · 1999-11-01
SUSPENDED
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsNCT00004999 · lead sponsor · 1999-08-01
SUSPENDED
Viracept Expanded Access ProgramNCT00002165 · lead sponsor
COMPLETED
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)NCT00002170 · lead sponsor
COMPLETED
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)NCT00005001 · lead sponsor
COMPLETED
Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed InfantsNCT00002164 · lead sponsor
COMPLETED
A Study of Viracept in HIV-Positive WomenNCT00002171 · lead sponsor
COMPLETED
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3NCT00002185 · lead sponsor
COMPLETED
A Study of Viracept in AIDS Patients With Cytomegalovirus RetinitisNCT00002169 · lead sponsor
COMPLETED
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)NCT00005002 · lead sponsor
UNKNOWN
Nelfinavir and M8 Drug-level Monitoring in HIV-1 InfectionNCT00205283 · collaborator · 2003-08-01
COMPLETED
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVNCT00006441 · collaborator · 2003-02-01
COMPLETED
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease InhibitorsNCT00002235 · collaborator
COMPLETED

Sponsor roles

lead sponsor14
collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.